“培力”安醣錠 15 毫克

Страна: Тайван

Език: китайски

Източник: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Активна съставка:

PIOGLITAZONE HYDROCHLORIDE

Предлага се от:

培力藥品工業股份有限公司 台中市西屯區工業六路11號 (52260152)

АТС код:

A10BG03

Лекарствена форма:

錠劑

Композиция:

PIOGLITAZONE HYDROCHLORIDE (6820400910) (eq. Pioglitazone 15mg)MG

Броя в опаковка:

鋁箔盒裝;;塑膠瓶裝

Клас:

製　劑

Вид предписание :

須由醫師處方使用

Произведено от:

培力藥品工業股份有限公司 台中市西區工業區六路１１號 TW

Терапевтична област:

pioglitazone

Терапевтични показания:

第二型糖尿病患者(非胰島素依賴型糖尿病，NIDDM)。

Каталог на резюме:

有效日期: 2028/06/16; 英文品名: Piotas Tablets 15 mg“P.L.”

Дата Оторизация:

2008-06-16

Листовка

CH
3
N
O
O
S
O
NH
HCl
(mg/dL)
()
(*)
(mg/dL)
()
(*)
(mg/dL)
()
(*)
(mg/dL)
()
(*)
*Adjusted for baseline, pooled center, and pooled center by treatment
interaction
†
p < 0.05 vs.
N=79
262.8
4.8%
N=79
41.7
8.1%
N=65
138.8
4.8%
N=79
224.6
4.4%
Pioglitazone 15 mg
N=79
283.8
-9.0%
†
N=79
40.4
14.1%
†
N=63
131.9
7.2%
N=79
220.0
4.6%
Pioglitazone 30 mg
N=84
261.1
-9.6%
†
N=83
40.8
12.2%
N=74
135.6
5.2%
N=84
222.7
3.3%
Pioglitazone 45 mg
N=77
259.7
-9.3%
†
N=77
40.7
19.1%
†
N=62
126.8
6.0%
N=77
213.7
6.4%
HbA1c (%)
(mg/dL)
†
Adjusted for baseline, pooled center and pooled center by treatment
interaction
*p ≤ 0.050 vs.
N=79
10.4
0.7
N=79
268
9
Pioglitazone 15 mg
N=79
10.2
-0.3
-1.0*
N=79
267
-30
-39*
Pioglitazone 30 mg
N=85
10.2
-0.3
-1.0*
N=84
269
-32
-41*
Pioglitazone 45 mg
N=76
10.3
-0.9
-1.6*
N=77
276
-56
-65*
HbA1c (%)
(mg/dL)
HbA1c (%)
(mg/dL)
†
Adjusted for baseline and pooled center
N=25
9.3
9.0
0.6
N=25
223
229
16
N=54
9.3
10.9
0.8
N=54
222
285
4
Pioglitazone 15 mg
N=26
10.0
9.9
-0.8
-1.4
N=26
245
251
-37
-52
N=53
9.0
10.4
-0.1
-1.0
N=53
209
275
-32
-36
Pioglitazone 30 mg
N=26
9.5
9.3
-0.6
-1.3
N=26
239
225
-41
-56
N=59
9.1
10.4
-0.0
-0.9
N=58
230
286
-27
-31
Pioglitazone 45 mg
N=21
9.8
10.0
-1.9
-2.6
N=21
239
235
-64
-80
N=55
9.0
10.6
-0.6
-1.4
N=56
215
292
-55
-59
HbA1c (%)
(mg/dL)
Adjusted for baseline, pooled center and pooled center by treatment
interaction.
*p<0.050 vs.
N=83
10.8
0.9
N=78
279
8
Pioglitazone 30 mg
N=85
10.3
-0.6
-1.5*
N=82
268
-44
-62*
Pioglitazone 45mg
N=85
10.8
-0.6
-1.5*
N=85
281
-50
-68*
HbA1c
(mg/dL)
Adjusted for baseline, pooled center and pooled center by treatment
interaction
*p<0.050 vs.
N=93
10.3
0.8
N=91
270
8
Pioglitazone 30 mg
N=100
10.5
-0.6
-1.4*
N=99
273
-50
-58*
Thiazolidinediones
(Rosiglitazone
Pioglitazone)
()
Pioglitazone
( NYHAClassIII IV cardiac status)
Pioglitazone 15/30mg
Lactose, Hydroxypropylcellulose, Povidone K-30, Sodium Starch
Glycolate, Magnesium Stearate
(NIDDM)
Pioglitazone
pioglitazone
pioglitazone
sulfonylurea
metformininsulin
HbA1c
HbA1c